TAMBERI, SERENA
 Distribuzione geografica
Continente #
NA - Nord America 89
AS - Asia 62
EU - Europa 33
SA - Sud America 5
AF - Africa 4
Totale 193
Nazione #
US - Stati Uniti d'America 85
SG - Singapore 27
IT - Italia 16
CN - Cina 14
HK - Hong Kong 8
DE - Germania 5
VN - Vietnam 5
CA - Canada 3
NL - Olanda 3
BD - Bangladesh 2
BR - Brasile 2
CI - Costa d'Avorio 2
FR - Francia 2
IN - India 2
PK - Pakistan 2
SE - Svezia 2
UY - Uruguay 2
AR - Argentina 1
AT - Austria 1
BY - Bielorussia 1
FI - Finlandia 1
GB - Regno Unito 1
KG - Kirghizistan 1
MX - Messico 1
NG - Nigeria 1
PH - Filippine 1
PL - Polonia 1
SN - Senegal 1
Totale 193
Città #
San Jose 20
Ashburn 17
Singapore 16
Dallas 9
Hong Kong 7
Santa Clara 6
Beijing 4
Cascina 4
Los Angeles 4
New York 4
Columbus 3
Montreal 3
Munich 3
Rome 3
Shanghai 3
Abidjan 2
Boardman 2
Florence 2
Montevideo 2
Verona 2
Amsterdam 1
Augusta 1
Bishkek 1
Canoas 1
Cao Lanh 1
Changchun 1
Chennai 1
Dakar 1
Davao City 1
Denver 1
Düsseldorf 1
Elk Grove Village 1
Frankfurt am Main 1
Grand Rapids 1
Guangzhou 1
Guruvāyūr 1
Haiphong 1
Hanoi 1
Ho Chi Minh City 1
Jackson 1
Karachi 1
Kent 1
Lagos 1
Lahore 1
London 1
Mexico City 1
Milan 1
Minsk 1
Ogden 1
Orem 1
Osasco 1
Padova 1
Quận Bốn 1
Redondo Beach 1
Riverside 1
Romeoville 1
Seattle 1
Shenyang 1
Stockholm 1
Tivoli 1
Tostado 1
Turku 1
Warsaw 1
Washington 1
Totale 160
Nome #
Encorafenib plus cetuximab with or without binimetinib in patients with BRAF V600E-mutated metastatic colorectal cancer: real-life data from an Italian multicenter experience 99
Liver metastases do not predict resistance to the addition of atezolizumab to first-line FOLFOXIRI plus bevacizumab in proficient MMR metastatic colorectal cancer: a secondary analysis of the AtezoTRIBE study 97
Totale 196
Categoria #
all - tutte 520
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 520


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2022/202310 0 0 0 0 0 0 4 1 3 0 2 0
2023/202412 0 2 2 1 2 3 0 0 0 0 2 0
2024/202553 1 1 0 2 2 7 0 5 12 4 5 14
2025/2026121 15 8 12 11 13 10 17 7 4 8 13 3
Totale 196